These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 26632856)
21. MiR-205 suppresses autophagy and enhances radiosensitivity of prostate cancer cells by targeting TP53INP1. Wang W; Liu J; Wu Q Eur Rev Med Pharmacol Sci; 2016; 20(1):92-100. PubMed ID: 26813458 [TBL] [Abstract][Full Text] [Related]
22. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair. Maranto C; Udhane V; Hoang DT; Gu L; Alexeev V; Malas K; Cardenas K; Brody JR; Rodeck U; Bergom C; Iczkowski KA; Jacobsohn K; See W; Schmitt SM; Nevalainen MT Clin Cancer Res; 2018 Apr; 24(8):1917-1931. PubMed ID: 29483142 [No Abstract] [Full Text] [Related]
23. miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. Huang X; Taeb S; Jahangiri S; Emmenegger U; Tran E; Bruce J; Mesci A; Korpela E; Vesprini D; Wong CS; Bristow RG; Liu FF; Liu SK Cancer Res; 2013 Dec; 73(23):6972-86. PubMed ID: 24145350 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Kong Z; Xie D; Boike T; Raghavan P; Burma S; Chen DJ; Habib AA; Chakraborty A; Hsieh JT; Saha D Cancer Res; 2010 Apr; 70(7):2829-39. PubMed ID: 20332235 [TBL] [Abstract][Full Text] [Related]
26. Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells. Wang L; Liu C; Li C; Xue J; Zhao S; Zhan P; Lin Y; Zhang P; Jiang A; Chen W Gene; 2015 Nov; 572(2):252-8. PubMed ID: 26164758 [TBL] [Abstract][Full Text] [Related]
27. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101 [TBL] [Abstract][Full Text] [Related]
29. Adamantanyl-histone deacetylase inhibitor H6CAHA exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivity. Konsoula Z; Cao H; Velena A; Jung M Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1541-8. PubMed ID: 21277099 [TBL] [Abstract][Full Text] [Related]
30. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. Ke G; Liang L; Yang JM; Huang X; Han D; Huang S; Zhao Y; Zha R; He X; Wu X Oncogene; 2013 Jun; 32(25):3019-27. PubMed ID: 22847611 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2. Ma S; Chan YP; Kwan PS; Lee TK; Yan M; Tang KH; Ling MT; Vielkind JR; Guan XY; Chan KW Cancer Res; 2011 Jan; 71(2):583-92. PubMed ID: 21224345 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-196b enhances the radiosensitivity of SNU-638 gastric cancer cells by targeting RAD23B. Shen YN; Bae IS; Park GH; Choi HS; Lee KH; Kim SH Biomed Pharmacother; 2018 Sep; 105():362-369. PubMed ID: 29864624 [TBL] [Abstract][Full Text] [Related]
33. Constitutive mRNA expression of DNA repair-related genes as a biomarker for clinical radio-resistance: A pilot study in prostate cancer patients receiving radiotherapy. Hümmerich J; Werle-Schneider G; Popanda O; Celebi O; Chang-Claude J; Kropp S; Mayer C; Debus J; Bartsch H; Schmezer P Int J Radiat Biol; 2006 Aug; 82(8):593-604. PubMed ID: 16966187 [TBL] [Abstract][Full Text] [Related]
34. miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis. El Bezawy R; Cominetti D; Fenderico N; Zuco V; Beretta GL; Dugo M; Arrighetti N; Stucchi C; Rancati T; Valdagni R; Zaffaroni N; Gandellini P Cancer Lett; 2017 Jun; 395():53-62. PubMed ID: 28274892 [TBL] [Abstract][Full Text] [Related]
35. miR-221/222 confers radioresistance in glioblastoma cells through activating Akt independent of PTEN status. Li W; Guo F; Wang P; Hong S; Zhang C Curr Mol Med; 2014 Jan; 14(1):185-95. PubMed ID: 24295494 [TBL] [Abstract][Full Text] [Related]
36. Zerumbone Regulates DNA Repair Responding to Ionizing Radiation and Enhances Radiosensitivity of Human Prostatic Cancer Cells. Chiang PK; Tsai WK; Chen M; Lin WR; Chow YC; Lee CC; Hsu JM; Chen YJ Integr Cancer Ther; 2018 Jun; 17(2):292-298. PubMed ID: 28602099 [TBL] [Abstract][Full Text] [Related]
37. MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation. Moretti L; Niermann K; Schleicher S; Giacalone NJ; Varki V; Kim KW; Kopsombut P; Jung DK; Lu B Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1189-97. PubMed ID: 21514073 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers. Rane JK; Erb HH; Nappo G; Mann VM; Simms MS; Collins AT; Visakorpi T; Maitland NJ Oncotarget; 2016 Aug; 7(32):51965-51980. PubMed ID: 27340920 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cells. Mao A; Zhao Q; Zhou X; Sun C; Si J; Zhou R; Gan L; Zhang H Sci Rep; 2016 Jun; 6():27346. PubMed ID: 27250340 [TBL] [Abstract][Full Text] [Related]
40. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models. Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]